Publications by authors named "Douglas Venancio Pereira Marques"
Cancers (Basel)
August 2019
Article Synopsis
- Cachexia is a serious syndrome seen in NSCLC, marked by muscle loss and poor prognosis, and the search for reliable biomarkers to predict outcomes is ongoing.
- Researchers analyzed CT images and tumor data from 89 NSCLC patients to find potential biomarkers linked to low muscle mass.
- The study identified interleukin (IL)-8 as a significant biomarker that not only predicts worse prognosis in NSCLC but also induces muscle cell atrophy in lab tests.
